Skip to content

UNAIDS reduces estimate of global HIV prevalence to 33 million

'Brazilian model' saves over $1 billion in anti-HIV treatment costs

Differing approaches to risk reduction needed for cocaine or heroin injectors

UNAIDS: Progress seen in most global regions, but much more needs to be done

Failure to suppress viral load more likely with nevirapine than efavirenz if ART started during TB treatment

HIV vaccine may have made people more vulnerable to infection

Is serological testing for HIV at 18 months of age in children born to HIV-infected mothers still reliable?

HIV superinfection in chronically infected patients reported

Raltegravir takes key step towards European approval